Company intelligence / Profile preview

AVM Labs

Ownership: Private
Development stage: Other

Overview

AVM Labs, formerly known as Thyrocare Gulf Laboratories, operates as a premier diagnostic laboratory based in the United Arab Emirates. The company provides comprehensive and high-quality testing services across endocrinology, infectious diseases, oncology, and genetic testing. It leverages advanced technological infrastructure to deliver accurate results with swift turnaround times and maintains stringent quality standards for healthcare providers and patients throughout the region.

Industry: Molecular Diagnostics

Partnerships

No major pharmaceutical or biotech partnerships listed; likely partners with regional healthcare providers and hospitals for diagnostic services.

Beyond the preview

Go deeper on AVM Labs.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on AVM Labs.

Explore the full profile